Genmab (GMAB) P/E (2014 - 2026)
Genmab (GMAB) P/E from Dec 31, 2014 to Jul 21, 2026. The TTM Genmab (GMAB) P/E is 136.84. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Genmab (GMAB)
| Year | P/E | Change |
|---|---|---|
| 2026 | 136.84 | -10.74% |
| 2025 | 153.30 | +789.73% |
| 2024 | 17.23 | -50.84% |
| 2023 | 35.05 | -1.49% |
| 2022 | 35.58 | -36.01% |
| 2021 | 55.61 | +51.22% |
| 2020 | 36.77 | -18.49% |
| 2019 | 45.11 | +1.33% |
| 2018 | 44.52 | -27.24% |
| 2017 | 61.19 | -33.85% |
| 2016 | 92.51 | +28.50% |
| 2015 | 71.99 | -76.14% |
| 2014 | 301.74 | N/A |
Comparison Genmab (GMAB) P/E with competitors
Genmab (GMAB) P/E is 136.84.